Explore more Articles in

BioTech

The Energy Report: Listen to What OPEC Says

prices are shaking off a larger-than-expected OPEC production increase as the precious metals get hit by a ton of bricks after President Trump...

Why Is KalVista Pharmaceuticals Stock Soaring On Monday? – KalVista Pharma (NASDAQ:KALV)

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals Inc.’s KALV Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult...

Dow Jones Forecast: Political Tensions and Tariff Risks Weigh on Outlook

US futures are rising on Monday after the extended holiday weekend. Uncertainty surrounding U.S. trade tariff policies are keeping investors cautious, whilst Tesla (NASDAQ:)...

Why Is Apogee Therapeutics Stock Soaring On Monday? – Apogee Therapeutics (NASDAQ:APGE)

Apogee Therapeutics Inc. APGE stock is experiencing a significant surge, trading almost 29% higher in premarket on Monday.This substantial increase in stock price follows...
BioTech

Mineralys Therapeutics: Investigational Drug Shows Benefit In Hypertensive Patients With Chronic Kidney Disease, Stock Jumps – Mineralys Therapeutics (NASDAQ:MLYS)

Mineralys Therapeutics, Inc. MLYS revealed topline data Tuesday from its Phase 2 Explore-CKD trial, which evaluated the safety and efficacy of 25 mg of...
BioTech

AbbVie’s Cancer Drug Venetoclax Falls Short In Phase 3 Combination Trial For Myelodysplastic Syndromes – AbbVie (NYSE:ABBV)

AbbVie Inc ABBV on Monday announced an update from the global Phase 3 VERONA trial evaluating venetoclax in combination with azacitidine for newly diagnosed...
BioTech

Why Is Dyne Therapeutics Stock Trading Lower On Tuesday? – Dyne Therapeutics (NASDAQ:DYN)

Dyne Therapeutics, Inc. DYN stock is trading lower after the company announced on Tuesday that it had revised the ongoing Registrational Expansion Cohort in...
BioTech

Eli Lilly Expands Into Gene Editing With Verve Therapeutics Acquisition – Eli Lilly (NYSE:LLY), Verve Therapeutics (NASDAQ:VERV)

Weight Loss drug maker Eli Lilly And Co LLY has agreed to acquire Verve Therapeutics, Inc. VERV, a Boston-based clinical-stage company developing genetic medicines...
BioTech

Supernus Pharma Acquires Maker Of Postpartum Depression Drug Zurzuvae In $795 Million Deal – Sage Therapeutics (NASDAQ:SAGE), Biogen (NASDAQ:BIIB)

Supernus Pharmaceuticals, Inc. SUPN on Monday agreed to acquire Sage Therapeutics, Inc. SAGE for $12.00 per share in cash, or an aggregate of up to...
BioTech

Jaishankar Receives Messi Jersey As Gift From Argentina Minister, Discusses Biotechnology, Atomic Energy

EXTERNAL Affairs Minister S Jaishankar on Monday met with Daniel Filmus, Argentina's minister of science and technology. Ministers discussed bilateral cooperation in atomic energy,...
moe1 -
1...15161718Page 16 of 18

- A word from our sponsors -

Most Popular

Disclaimer: The content provided is for informational purposes only. We aim to keep the content current and accurate by updating it frequently. Sometimes the actual data can differ from what's stated on our website. Buttonwoodnews.com is an independent platform. While we are independent, we may be compensated for advertisements, sponsored products, or when you click on a link on our website. The contributors and authors are not registered or certified financial advisors. You should consult a financial professional before making any financial decisions.

Copyright © Button Wood News.